| Sunlands Technology Group Announces Unaudited First Quarter 2024 Financial Results |
Globe Newswire |
05/24 |
12:30 |
| Flash News: OKX DEX Announces Ring Protocol Integration, Enabling Improved Liquidity on Blast |
Globe Newswire |
05/24 |
12:26 |
| Flash News: OKX Wallet Now Integrated with Cookie3 |
Globe Newswire |
05/24 |
11:15 |
| Atrogi Announces Publication on Advancements in Combatting Obesity and Metabolic Complications |
Globe Newswire |
05/24 |
11:00 |
| Flash News: OKX Wallet to Host 'OKX Web3 Mixer @Consensus ft. ZetaChain & Privasea' During Consensus 2024 |
Globe Newswire |
05/24 |
10:47 |
| Flash News: OKX Adds dYdX's Token to On-Chain Earn Product |
Globe Newswire |
05/24 |
10:14 |
| Correction: CBiGroup Completes $15M Series A Funding, Focuses on R&D |
Globe Newswire |
05/24 |
06:59 |
| Introducing Optimum AI: Revolutionizing DeFi with Text-Based Trading on WhatsApp and Telegram |
Globe Newswire |
05/24 |
05:37 |
| HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting |
Globe Newswire |
05/24 |
04:00 |
| Elevating Scientific Rigor with Umbrella Labs' Gonadorelin Peptide and Precision Calculator |
Globe Newswire |
05/24 |
03:17 |
| LexinFintech Holdings Ltd. Reports First Quarter 2024 Unaudited Financial Results |
Globe Newswire |
05/24 |
03:00 |
| AXTI Stockholders: Robbins LLP Reminds AXTI Stockholders of Securities Fraud Class Action Against AXT, Inc. |
Globe Newswire |
05/24 |
02:37 |
| The Dominican Republic and Purdue University Sign MOU to Drive Semiconductor Growth |
Globe Newswire |
05/24 |
02:01 |
| Huize Holding Limited Reports First Quarter 2024 Unaudited Financial Results |
Globe Newswire |
05/24 |
02:00 |
| Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting |
Globe Newswire |
05/24 |
02:00 |
| Mountain America Credit Union Named Utah's Leading SBA Lender for Third Consecutive Year |
Globe Newswire |
05/24 |
01:41 |
| 3Daughters to Participate in Women’s Health Panel During the 2024 BIO International Convention in San Diego, CA, June 3-6 |
Globe Newswire |
05/24 |
01:33 |
| Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting |
Globe Newswire |
05/24 |
01:30 |
| INTC Stockholders: Robbins LLP Reminds INTC Stockholders of Securities Fraud Class Action Against Intel Corporation |
Globe Newswire |
05/24 |
01:21 |
| BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting |
Globe Newswire |
05/24 |
01:05 |
| I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024 |
Globe Newswire |
05/24 |
01:05 |
| Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO |
Globe Newswire |
05/24 |
01:03 |
| Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting |
Globe Newswire |
05/24 |
01:00 |
| Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting |
Globe Newswire |
05/24 |
01:00 |
| Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors |
Globe Newswire |
05/24 |
01:00 |
